Because ER-positive breast cancer cells rely mostly on ERα signaling pathway for their proliferation, and activation of GR has negative effect on it, it is conceivable that GR expression and activation is associated with better treatment outcome in ER-positive breast cancers. This evidence concerns the gene ESR1 and breast cancer.